Clonal Technologies offers a comprehensive range of products and services to partner organisations in the implementation of drug testing including breath, saliva and urine testing and analysers.
| Website | http://clonaltech.com.au |
| Revenue | $192000 |
| Employees | 1 (1 on RocketReach) |
| Address | 33 Fulcrum St, Richlands, Queensland 4077, AU |
| Phone | +61 1300 795 335 |
| Fax | +61 7 3859 2998 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+5 more
(view full list)
|
| Industry | Retail |
| Keywords | Drug Testing, Saliva Testing, Urine Testing, Analytical Testing, Lab Equipment, Testing Services, Clinical Diagnostics, Forensic Toxicology, Substance Testing, Toxicology Testing, Point Of Care Testing, Medical Devices, Diagnostic Tools, Healthcare Technology, Lab Technology, Testing Supplies, Biomedical Technology |
| Competitors | GenScript, abcam, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck Group, Cell Signaling Technology (CST), Lonza, Promega Corporation, Vector Laboratories, Inc. +35 more (view full list) |
| SIC | SIC Code 50 Companies, SIC Code 504 Companies |
| NAICS | NAICS Code 4234 Companies, NAICS Code 42345 Companies, NAICS Code 423 Companies, NAICS Code 42 Companies |
Looking for a particular Clonal Technologies PTY Ltd. employee's phone or email?
The Clonal Technologies PTY Ltd. annual revenue was $192000 in 2026.
John Dubois is the CEO of Clonal Technologies PTY Ltd..
1 people are employed at Clonal Technologies PTY Ltd..
Clonal Technologies PTY Ltd. is based in Richlands, Queensland.
The NAICS codes for Clonal Technologies PTY Ltd. are [4234, 42345, 423, 42].
The SIC codes for Clonal Technologies PTY Ltd. are [50, 504].